Pharmacokinetics and dosing requirements of digoxin in pregnant women treated for fetal supraventricular tachycardia.

about

Drug Dosing in Pregnant Women: Challenges and Opportunities in Using Physiologically Based Pharmacokinetic Modeling and Simulations.Improvement of Adequate Digoxin Dosage: An Application of Machine Learning Approach

P2860

Q47724161-9DDDD989-FBBC-46CF-9FDC-37158335B440 Q58766132-5BBC082C-1F3D-4441-A628-3F216052ECB5

P2860

Pharmacokinetics and dosing requirements of digoxin in pregnant women treated for fetal supraventricular tachycardia.

Item

http://www.wikidata.org/entity/Q47795256

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Pharmacokinetics and dosing re ...... supraventricular tachycardia.

@en

Pharmacokinetics and dosing re ...... supraventricular tachycardia.

@nl

type

Item

label

Pharmacokinetics and dosing re ...... supraventricular tachycardia.

@en

Pharmacokinetics and dosing re ...... supraventricular tachycardia.

@nl

prefLabel

Pharmacokinetics and dosing re ...... supraventricular tachycardia.

@en

Pharmacokinetics and dosing re ...... supraventricular tachycardia.

@nl

P1476

Pharmacokinetics and dosing re ...... l supraventricular tachycardia

@en

P2093

J German Sanchez-Hernandez

http://www.w3.org/2001/XMLSchema#string

Jose M Lanao

http://www.w3.org/2001/XMLSchema#string

Luisa Garcia-Cuenllas Alvarez

http://www.w3.org/2001/XMLSchema#string

M Victoria Calvo

http://www.w3.org/2001/XMLSchema#string

P2860

Estimation of population characteristics of pharmacokinetic parameters from routine clinical data

Transplacental treatment of fetal tachycardia: implications of drug transporting proteins in placenta.

Perinatal arrhythmias: diagnosis and management.

Evaluation of a sex-based difference in the pharmacokinetics of digoxin.

The status of pharmacometrics in pregnancy: highlights from the 3(rd) American conference on pharmacometrics

Fetal supraventricular tachycardia, treating the baby by targeting the mother

Prenatal management with digoxin and sotalol combination for fetal supraventricular tachycardia: case report and review of literature.

Physiologic and pharmacokinetic changes in pregnancy.

Evaluation of therapeutic effect and cytokine change during transplacental Digoxin treatment for fetal heart failure associated with fetal tachycardia, a case-control study.

P304

911-917

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/17512433.2017.1344096

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Ana Martín Suárez

F Medina-Barajas

Jonás Samuel Pérez-Blanco

P577

2017-07-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28631514

http://www.w3.org/2001/XMLSchema#string

P921

7bèla

digoxin

Pharmacokinetics and dosing requirements of digoxin in pregnant women treated for fetal supraventricular tachycardia.

about

P2860

P2860

Pharmacokinetics and dosing requirements of digoxin in pregnant women treated for fetal supraventricular tachycardia.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P921